Press Releases

 

GW Conference Call with Pharmaceuticals Analysts

3 December 2004

GW hosted a conference call with pharmaceuticals analysts today.... more

GW Announces Positive Preliminary Results with its Cannabis-based Medicine (Sativex®) in Phase III Multiple Sclerosis Trial

21 June 2004

GW Pharmaceuticals announces positive preliminary results in a Phase III clinical trial to assess the effects of Sativex® on spasticity in 189 patients with Multiple Sclerosis (MS).... more

GW Announces Positive Preliminary Results with its Cannabis Medicine in Phase III Neuropathic Pain Trial

15 June 2004

GW Pharmaceuticals announces positive preliminary results in a Phase III clinical trial with Sativex® in 125 patients with neuropathic (nerve damage) pain.... more

GW Announces Positive Preliminary Results with its Cannabis-based Medicine in Phase II Rheumatoid Arthritis Pain Trial

9 June 2004

GW Pharmaceuticals plc announces positive preliminary results in a Phase II clinical trial in patients with pain caused by Rheumatoid Arthritis.... more